Search all medical codes

Encounter for screening for human immunodeficiency virus [HIV]

ICD10CM code

Medical Policies and Guidelines for Encounter for screening for human immunodeficiency virus [HIV]

Related policies from health plans

Apretude (cabotegravir extended-release injectable suspension) (PG158)
Apretude (cabotegravir extended-release injectable suspension) (PG158)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Nucleic Acid Pathogen Testing - (0530)
Preventive Care Services - (A004)
Transvaginal Ultrasound, Non-Obstetrical - (0398)

Similar Codes


ICD10CM codes

Z11.4 - Encounter for screening for human immunodeficiency virus [HIV]
Z20.6 - Contact with and (suspected) exposure to human immunodeficiency virus [HIV]
Z83.0 - Family history of human immunodeficiency virus [HIV] disease
Z11.5 - Encounter for screening for other viral diseases
B20 - Human immunodeficiency virus [HIV] disease
Z11.3 - Encounter for screening for infections with a predominantly sexual mode of transmission
Z71.7 - Human immunodeficiency virus [HIV] counseling
Z11.52 - Encounter for screening for COVID-19
Z11.59 - Encounter for screening for other viral diseases
Z11.51 - Encounter for screening for human papillomavirus (HPV)

HCPCS codes

G0432 - Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, scree
G0433 - Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 an
G0435 - Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening
G0475 - Hiv antigen/antibody, combination assay, screening
T1023 - Screening to determine the appropriateness of consideration of an individual for participation in a
D0190 - Screening of a patient
G0472 - Hepatitis c antibody screening, for individual at high risk and other covered indication(s)
J3485 - Injection, zidovudine, 10 mg
G9228 - Chlamydia, gonorrhea and syphilis screening results documented (report when results are present for
G0431 - Drug screen, qualitative; multiple drug classes by high complexity test method (e.g., immunoassay, e

CPT4 codes

4293F - Patient screened for high-risk sexual behavior (HIV)
3511F - Chlamydia and gonorrhea screenings documented as performed (HIV)
3510F - Documentation that tuberculosis (TB) screening test performed and results interpreted (HIV) (IBD)
86702 - Antibody; HIV-2
87390 - Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-l
87806 - Infectious agent antigen detection by immunoassay with direct optical observation; HIV-1 antigen(s),
86701 - Antibody; HIV-1
86689 - Antibody; HTLV or HIV antibody, confirmatory test (eg, Western Blot)
87539 - Infectious agent detection by nucleic acid (DNA or RNA); HIV-2, quantification, includes reverse tra
87536 - Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification, includes reverse tra